Autoimmune Disorders

Autoimmune disorders occur when the immune system mistakenly attacks the body’s own healthy tissue, driven by genetic and environmental factors. Conditions such as type 1 diabetes, alopecia areata, rheumatoid arthritis, and lupus result in the immune system’s inability to distinguish between foreign and self-antigens, causing chronic inflammation and tissue damage. Treating autoimmune disorders is challenging, requiring therapies that suppress the autoimmunity without compromising overall immune defense.

Type 1 Diabetes

Diabetes is one of the most common non-communicable diseases worldwide and a leading cause of death in developed nations, with rising prevalence across developing and newly industrialized countries as well. Its complications, including cardiovascular disease, stroke, neuropathy, amputation, kidney failure, and blindness, drive increasing disability, reduced life expectancy, and substantial healthcare costs.

Type 1 diabetes (T1D) is a chronic autoimmune disease in which immune cells destroy insulin-producing pancreatic beta cells, leading to progressive insulin loss, persistent hyperglycemia, and broader metabolic disturbances. There is no cure. Patients rely on lifelong insulin therapy, which cannot fully replicate the body’s natural insulin patterns, leaving them at risk for complications ranging from hypoglycemia and ketoacidosis to cardiovascular disease and neuropathy. Daily T1D management is demanding, requiring constant glucose monitoring and dosing adjustments that often diminish quality of life.

T1D’s complexity, rooted in both immune dysregulation and beta cell dysfunction, has made long-term solutions elusive despite extensive research into stem cell and cell-based therapies. Reversing the disease will likely require novel approaches that simultaneously restore immune tolerance and regenerate functional beta cells.

Alopecia Areata

Alopecia areata is a common autoimmune disorder that affects millions of people worldwide, causing sudden non-scarring hair loss without visible skin inflammation. It typically begins with one or multiple patches of hair loss that can enlarge in a centrifugal pattern; in more severe cases, it can progress to loss of the entire scalp (alopecia totalis) or body (alopecia universalis). While its exact cause remains unclear, alopecia areata is believed to result from a loss of immune privilege in hair follicles, where T cell infiltration and proinflammatory signaling attack follicles in their growth phase.

Alopecia areata affects nearly 2% of the general population at some point during their lifetime and follows an unpredictable course. No cure currently exists, and available treatments are limited due to lack of efficacy, safety concerns, or inability to prevent future relapse of the disease.